Nuwellis, Inc. (NUWE)
NASDAQ: NUWE · Real-Time Price · USD
9.10
-0.50 (-5.21%)
At close: Aug 1, 2025, 4:00 PM
9.11
+0.01 (0.11%)
After-hours: Aug 1, 2025, 7:30 PM EDT
Accolade Employees
Nuwellis had 38 employees as of December 31, 2024. The number of employees decreased by 21 or -35.59% compared to the previous year.
Employees
38
Change (1Y)
-21
Growth (1Y)
-35.59%
Revenue / Employee
$231,237
Profits / Employee
-$259,158
Market Cap
1.04M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 38 | -21 | -35.59% |
Dec 31, 2023 | 59 | -11 | -15.71% |
Dec 31, 2022 | 70 | 0 | - |
Dec 31, 2021 | 70 | 5 | 7.69% |
Dec 31, 2020 | 65 | -1 | -1.52% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
NUWE News
- 9 days ago - Nuwellis Participates in the Virtual Investor “What's Your Story” Summer Spotlight On-Demand Conference - GlobeNewsWire
- 9 days ago - Nuwellis Regains Compliance with Nasdaq Listing Requirements - GlobeNewsWire
- 10 days ago - Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025 - GlobeNewsWire
- 15 days ago - Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care - GlobeNewsWire
- 17 days ago - Nuwellis Secures New U.S. Patent, Strengthening Its Position as a Leader in Fluid Management Innovation - GlobeNewsWire
- 4 weeks ago - Nuwellis Appoints John Erb as Chief Executive Officer - GlobeNewsWire
- 7 weeks ago - Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option - GlobeNewsWire
- 7 weeks ago - Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offering - GlobeNewsWire